About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Holy Cross 9th Annual Winter Oncology Symposium
https://www.hconcologysymposium.com/
9th Annual Winter Oncology Symposium
Lung Cancers
Gastrointestinal Cancers
Gyn Cancers
Breast Cancers
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreatment with anti-PD-L1 Develop a Recurrent Side Effect?
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Ibiayi Dagogo-Jack
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Ibiayi Dagogo-Jack
316 views
May 15, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:46
AstraZeneca Oncology
First-line Maintenance Treatment Option in Patients With HRD-Positiv…
Feat.
S. Lewin
Featured Video
19:51
AstraZeneca Oncology
Management Strategies for Fatigue and Asthenia in First-line Mainten…
Feat.
D. Czel,
C. Arn
Lung Cancers
23:25
Holy Cross 9th Annual Winter Oncology Symposium
The Use of EBUS in Early Detection of Lung Cancers
Feat.
S. Kosseifi
16:59
Holy Cross 9th Annual Winter Oncology Symposium
PD-L1 Monotherapy vs. PD-L1+Chemo Combination Therapy in Metastatic …
Feat.
I. Dagogo-Jack
15:56
Holy Cross 9th Annual Winter Oncology Symposium
Pneumonitis, Thyroiditis, Myocarditis, and Hepatitis as Side Effects…
Feat.
I. Dagogo-Jack
05:39
Holy Cross 9th Annual Winter Oncology Symposium
Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreat…
Feat.
I. Dagogo-Jack
23:13
Holy Cross 9th Annual Winter Oncology Symposium
Targeted Therapy and Related Side Effects in Advanced NSCLC
Feat.
L. Raez
15:04
Holy Cross 9th Annual Winter Oncology Symposium
Genomic Profiling for Metastatic NSCLC
Feat.
D. Drew
17:27
Holy Cross 9th Annual Winter Oncology Symposium
Stereotactic Radiotherapy in Stage I Lung Cancer
Feat.
L. Goyal,
V. Patel
